What is INDP's earnings growth forecast for 2025-2025?
(NASDAQ: INDP) Indaptus Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Indaptus Therapeutics's earnings in 2025 is -$15,747,780.
In 2025, INDP is forecast to generate -$22,127,533 in earnings, with the lowest earnings forecast at -$22,127,533 and the highest earnings forecast at -$22,127,533.
What is INDP's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: INDP) forecast ROE is -790.34%, which is considered weak.
What is INDP's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: INDP) Indaptus Therapeutics's current Earnings Per Share (EPS) is -$1.49. In 2025, INDP's EPS is forecast to hit -$1.38 (min: -$1.38, max: -$1.38).
What is INDP's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: INDP) forecast ROA is -408.89%, which is lower than the forecast US Biotechnology industry average of -1.27%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.